GE HealthCare Technologies Inc. (GEHC)
NASDAQ · Healthcare · Medical - Devices
Profile
GE HealthCare Technologies Inc.
- Exchange
- NASDAQ
- Ticker
- GEHC
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- US
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
Key facts
GE HealthCare Technologies Inc.: key facts
- GE HealthCare Technologies Inc. (NASDAQ: GEHC) is a Medical - Devices company in the Healthcare sector.
- In fiscal 2025, GE HealthCare Technologies Inc. reported revenue of $20.6B and net income of $2.1B.
- Revenue grew 4.1% a year over the last 4 fiscal years.
- Free cash flow was positive in 5 of the last 5 fiscal years.
- Net income was positive in 5 of the last 5 fiscal years.
- Over the last twelve months, revenue was $20.6B and net income was $1.8B.
MonkScore
GE HealthCare Technologies Inc.'s MonkScore
MonkScore
MonkScore range: 50–60
as of October 2026
Sector rank: 307 of 628 in Healthcare
How this score is madeDisclaimer
Pillar ranges
- Growth60–70
- Profitability60–70
- Quality60–70
- Market Conviction40–50
- Safety10–20
The MonkScore runs from 0 to 100. Each range is one of ten 10-point groups, from 0–10 to 90–100.
Each pillar's range uses the same ten groups. The exact score and the pillar scores are in the MonkStreet app.
Fundamentals
Figures from the statements
GE HealthCare Technologies Inc.'s annual figures and the last twelve months, in USD. Last report: 30 September 2026.
| Figure | Last 12 months | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $20.6B | $20.6B | $19.7B | $19.6B | $18.3B | $17.6B |
| Gross profit | $8.9B | $8.2B | $8.2B | $7.9B | $7.2B | $7.2B |
| Operating income | $2.7B | $2.8B | $2.6B | $2.4B | $2.5B | $2.8B |
| Net income | $1.8B | $2.1B | $2.0B | $1.6B | $1.9B | $2.2B |
| Operating cash flow | $1.7B | $2.0B | $2.0B | $2.1B | $2.1B | $1.6B |
| Capital expenditure | -$526.0M | -$482.0M | -$401.0M | -$387.0M | -$310.0M | -$248.0M |
| Free cash flow | $1.2B | $1.5B | $1.6B | $1.7B | $1.8B | $1.4B |
| Total debt | $10.4B | $10.0B | $9.4B | $9.9B | $8.6B | $437.0M |
| Cash | $2.9B | $4.5B | $2.9B | $2.5B | $1.4B | $556.0M |
Revenue growth a year
- 1-year
- 4.8%
- 3-year
- 4.0%
- 4-year
- 4.1%
Compound growth between fiscal years.
Peers
Similar companies
- TransMedics Group, Inc.NASDAQ:TMDXMonkScore range: 50–60
- Edwards Lifesciences CorporationNYSE:EWMonkScore range: 50–60
- OrthoPediatrics Corp.NASDAQ:KIDSMonkScore range: 60–70
- LivaNova PLCNASDAQ:LIVNMonkScore range: 60–70
- Bruker CorporationNASDAQ:BRKRMonkScore range: 60–70
- Novocure LtdNASDAQ:NVCRMonkScore range: 60–70
- SI-BONE, Inc.NASDAQ:SIBNMonkScore range: 60–70
- Stryker CorporationNYSE:SYKMonkScore range: 70–80
Compare
Compare with
Score my top stocks · 14-day free trial · card required · not charged during the trial · cancel in one click
MonkStreet provides research, not investment advice.
Page built on 31 October 2026.